Central nervous system disease in phase III studies for advanced HER2 positive breast cancer: A review
Author:
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference50 articles.
1. Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer;Gabos;J Clin Oncol,2006
2. Metastatic behavior of breast cancer subtypes;Kennecke;J Clin Oncol,2010
3. CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-01);Pestalozzi;Lancet Oncol,2013
4. Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer in the APHINITY trial: 6 Years' follow-up;Piccart;J Clin Oncol,2021
5. Adjuvant lapatinib and trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer: results from the randomized phase III adjuvant lapatinib and/or trastuzumab treatment optimization trial;Piccart-Gebhart;J Clin Oncol,2016
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design, synthesis, and anti-breast tumor activity of novel combretastatin A-4 analogues;Monatshefte für Chemie - Chemical Monthly;2023-09-29
2. Design, Synthesis, and Anti-tumor Activity of Novel 2-Aryl Benzimidazole Compounds;Anti-Cancer Agents in Medicinal Chemistry;2023-08
3. Epidemiology, clinical outcomes, and unmet needs of patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases: A systematic literature review;Cancer Treatment Reviews;2023-04
4. Assessment of Phase 3 Randomized Clinical Trials Including Patients With Leptomeningeal Disease;JAMA Oncology;2023-04-01
5. Comparative Efficacy of Tyrosine Kinase Inhibitors and Antibody–Drug Conjugates in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A Systematic Review and Network Meta-Analysis;Cancers;2022-07-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3